[RDHL] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
28-Apr-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- 48.17%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 6,513 61,800 85,757 64,359 6,291 8,360 4,007 8.42%
PBT 23,952 -71,669 -97,744 -76,173 -42,304 -38,820 -45,544 -
Tax 0 -12,424 16,567 12,844 1,330 727 6,285 -
NP 23,916 -59,245 -114,311 -89,017 -43,634 -38,820 -45,544 -
Tax Rate 0.00% - - - - - - -
Total Cost -17,403 121,045 200,068 153,376 49,925 47,180 49,551 -
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 367.19 -95.87 -133.30 -138.31 -693.59 -464.35 -1,136.61 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 3.69 -38.27 -98.27 -97.75 -58.78 -68.00 -104.00 -
EPS Diluted 3.69 -38.27 -98.27 -97.75 -58.78 -68.00 -104.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.